UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status
Unique ID issued by UMIN UMIN000017679
Receipt No. R000020491
Official scientific title of the study Phase II study of hypofractionated proton beam therapy for localized prostate cancer
Date of disclosure of the study information 2015/06/01
Last modified on 2016/06/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Phase II study of hypofractionated proton beam therapy for localized prostate cancer
Title of the study (Brief title) hypofractionated proton therapy for prostate cancer
Region
Japan

Condition
Condition Prostate cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To confirm the feasibility and efficacy of hypofractionated proton beam therapy for localized prostate cancer
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Phase II

Assessment
Primary outcomes 5-year grade 2 late toxicity rate
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Hypofractionation
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male
Key inclusion criteria T1c-T3aN0M0 Prostate cancer
Key exclusion criteria Severe complications such as heart failure, and liver dysfunction
other active malignant tumors
history of pelvis irradiation
not to allow discontinuing anticoagulant and antiplatelet therapy
severe cognitive impairment


Target sample size 120

Research contact person
Name of lead principal investigator Hideyuki Sakurai
Organization University of Tsukuba, Faculty of Medicine
Division name Radiation Oncology
Address 1-1-1, Tennodai, Tsukuba
TEL 029-853-7100
Email hsakurai@pmrc.tsukuba.ac.jp

Public contact
Name of contact person Hitoshi Ishikawa
Organization University of Tsukuba, Faculty of Medicine
Division name Radiation Oncology
Address 1-1-1, Tennodai, Tsukuba
TEL 029-853-7100
Homepage URL
Email hishikawa@pmrc.tsukuba.ac.jp

Sponsor
Institute Proton Medical Research Center, University of Tsukuba
Institute
Department

Funding Source
Organization Proton Medical Research Center, University of Tsukuba
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 01 Day

Progress
Recruitment status
Date of protocol fixation
2015 Year 04 Month 30 Day
Anticipated trial start date
2015 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 05 Month 26 Day
Last modified on
2016 Year 06 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020491

Research Plan
Registered date Registrant File name

Research case data specifications
Registered date Registrant File name

Research case data
Registered date Registrant File name


For inquiries about the use of UMIN clinical trial registration system, use this contact form .Fort other inquiries, use this contact form